Posted on 10/26/2021 4:09:20 PM PDT by george76
My mom has TOTALLY been on the Invermectin/ Frontline bandwagon from almost day one so has been taking Invermectin “preventatively” and consistently.
Talked to her the other day - yeah, she got COVID pretty bad. Just now getting over a 2 week long fight with the virus.
Yeah, Invermectin works just great alright.
Even the manufacturer (Merck) says that Invermectin does not work for Covid. Since they stand to make BILLIONS selling it if it did, why would they do that?
_______________________________________
Not sure if that is a snarky remark about Ivermectin and your mom or what. Ivermectin is mostly meant to keep you out of the hospital because it attacks the virus early and lessens the effects of the infection. The vax is no better than Ivermectin since it isn’t going to keep you from catching the aerosalized bioweapon or from getting sick. With regard to Big Pharma, it’s pretty obvious that it all comes down to money. Now, Big Pharma has declared war against aspirin because it’s being used to treat/prevent blood clots. The patents for HCQ, Ivermectin, and aspiran have long run out so they are open generics now and cheaper than dirt. You ought to be taking the lead of your mother.
So most of Congress let everyone else not in their families and close friends twist in the wind. Does the good samaritan law not apply to those who sent to represent us in Congress?
I do not know the motivation for demonizing this particular medication,” he added.
::::::::::::::::::::::::::::::::::
Proof of the damage that pot does to your brain.
“you’re forgetting that all the dem and commie critters got vaccinated back in December”
Perhaps, but the discrepancy predates the election - during campaign season, Republicans were getting the virus non-stop...but never Democrats. Something was going on, and Ivermectin was already known for months as a possible treatment.
Interesting.
Politician: “I did NOT have pharmaceutical relations with those drugs.”
“Since they (Merck) stand to make BILLIONS selling it if it did...”
No, you are wrong there. Ivermectin is off-patent, so they wouldn’t make anything selling it. They are only interested in selling drugs which they sank billions of R&D dollars into and are patent-protected for some years. Would you want to sell a drug for $2 a dose or $1,000 a dose?
Do you seriously believe that Merck would endorse Ivermectin? That’s because Merck has developed an Ivermectin substitute they will be pushing soon at $20 a pop. It’s called molnupiravir. It’s all about MONEY. People are so naive, it’s amazing.
“”I do not know the motivation for demonizing this particular medication ..”
1. “There can be no effective, approved and available alternative”.
Now you know.
Yep. Prof. Bessler (they don't share the same last name) cut the line to get into the Univ of Minnesota Hydroxychloroquine trial.
They mailed the Plaquenil to his home. He never had to leave the house.
It is about money, power, and culling the population.
Fun fact: Guesstimating a ridiculously wide rangespan of +/-100 isn't any kind of "fact", given the tiny population of 635 total Representatives + Senators.
If any of it is true -- and I'm anti-experimental serum -- that implicitly deserves a valid number, because "100-200" is some classically laughable FRacebooker spitballing right there.
Because Merck's Stromectol (Ivermectin) is $2 to make and $4 at wholesale. Despite its proven efficacy as an anthelmintic globally, that market is surprisingly crowded and it has never driven their bottom line.
June 2021, Merck received FDA's $1.2B public commitment for 1.7 million doses of COVID-disruptor molnupiravir, with a contractual prospectus for 10 million (more) doses in the future. That math is obviou$.
Or is it really "obviou$" on FRacebook. *sigh*. Jesus wept.
$1.2B / 1.7M doses = $1,416 per dose
x 10 million doses (note the 10 million in the agreement does not include the original issue)
= $14.16B dollars
Ivermectin total revenue to Merck over 40 years is no more than 2/5ths of that number. In fact, this article was just released 3 hours ago:
Merck’s COVID-19 pill could bring in up to $7 billion in sales next year"Merck & Co. Inc. predicts it will make between $5 billion and $7 billion in sales of its potentially game-changing new oral COVID-19 drug (molnupiravir) in 2022, assuming it’s granted regulatory authorization this year."
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.